Abstract | AIMS/INTRODUCTION: MATERIALS AND METHODS: Peripheral blood mononuclear cells were obtained from type 2 diabetes patients (n = 31) and healthy donors (n = 18), and Tim-3 expression on peripheral blood mononuclear cells was evaluated by flow cytometry. RESULTS: We showed the downregulated expression of Tim-3 on CD14+ monocytes from type 2 diabetes patients. In addition, the upregulated expression of Tim-3 on peripheral CD4+ T cells and CD8+ T cells was observed in the present study. The correlation analysis between Tim-3 expression on CD14+ monocytes and diabetes duration showed the longer diabetes duration time, the lower Tim-3 expression on CD14 monocytes. CONCLUSIONS: The present results suggest that Tim-3 might participate in the progression of type 2 diabetes by its negative regulation on these immune cells, and Tim-3 on CD14+ monocytes serves as a novel biological marker for diabetes duration in type 2 diabetes patients.
|
Authors | Wen-Jiang Yan, Peng Sun, Dan-Dan Wei, Shuang-Xi Wang, Jing-Jing Yang, Yi-Hui Li, Cheng Zhang |
Journal | Journal of diabetes investigation
(J Diabetes Investig)
Vol. 7
Issue 6
Pg. 867-873
(Nov 2016)
ISSN: 2040-1124 [Electronic] Japan |
PMID | 27182056
(Publication Type: Journal Article)
|
Copyright | © 2016 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd. |
Chemical References |
- Biomarkers
- CD4 Antigens
- CD8 Antigens
- HAVCR2 protein, human
- Hepatitis A Virus Cellular Receptor 2
- Lipopolysaccharide Receptors
|
Topics |
- Adult
- Aged
- Biomarkers
(metabolism)
- CD4 Antigens
(metabolism)
- CD8 Antigens
(metabolism)
- Diabetes Mellitus, Type 2
(diagnosis, immunology, metabolism)
- Disease Progression
- Female
- Hepatitis A Virus Cellular Receptor 2
(metabolism)
- Humans
- Lipopolysaccharide Receptors
(metabolism)
- Male
- Middle Aged
- Monocytes
(metabolism)
|